StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.05−0.12 (-5.53%)

Close on Nov 17, 2026Market cap $130.59MP/E –Yield –

MacroGenics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

MacroGenics's pe ratio was 17.9× on Jan 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 202417.9×+5.8
2023Dec 29, 202312.0×−88.8
2014Jan 31, 2014100.8×+31.3
2013Dec 31, 201369.5×–

More MacroGenics figures

See a number that looks wrong?